CNS Toxic & Metabolic Diseases - Lawlor, Scharer Flashcards
The majority of Lysosomal storage diseases follow what genetic inheritance pattern?
Name two X-linked exceptions to this
Autosomal recessive
Fabry Disease and Hunter Syndrome are X-linked recessive
Why is delayed diagnosis of LSDs especially bad?
Unrecognized or delayed treatment of LSDs can cause irreversible injury to the brain and major organs (or death).
What symptoms should arouse suspicion of metabolic disorder?
Nearly everything (see slide 6 for an unhelpful wall of text)
Describe some suspicious clinical presentations that may indicate metabolic disorder
All of the following are suspicious in the absence of more common etiologies or other explanation
- Unexplained lethargy, confusion, comnolescence, coma
- Unexplained metabolic acidosis/alkalosis
- Excessive lactate or ketosis
- Persistent or recurrent hypoglycemia
- Chronic or worsening symptoms
- Unusual MRI, EEG, or pathology findings
- Unusual combination of findings indicating more than one etiology (Occam’s razor)
For the unresponsive patient with unexplained lethargy, confusion, or coma, what should you do next? Hints:
- Exam
- Blood chemistry
- Who can help?
- Immediate treatment
- Metabolic work-up
- Alternatives
- Get a good PE and PMI (duh)
- STAT glucose, ammonia, and blood pH
- also: check electrolytes, LFTs, lactate, and urinalysis
- Call a metabolic specialist (too bad this is never an option on boards)
- store a ‘critical sample’ for acute reference
- Start IV glucose ASAP
- Metabolic work-up: acylcarnitine profile, amino acid profile, urine organic acid profile (look for things that are non-normal in metabolic diseases)
- Consider alternatives: infection, intoxication, idiopathic)
Name the deficient enzyme in the following diseases:
Tay-Sachs disease
Sandhoff disease
GM2 Gangliosidosis variant AB
Hexosaminidase A
Hexosaminidase B
Activator protein
Are PKU or galactosemia considered lysosomal storage disorders? Why?
Is poisoning considered a lysosomal storage disease?
No - they involve accumulation of active metabolites
No - poisoning involves accumulation of active substrates
LSD accumulations are **inert substrates/metabolites. **However, silicosis and abestiosis are not considered defects of lysosomal function.
Tay-Sachs Disease:
- Especially prevalent in which ethnic population?
- Which chromosome is affected?
- Diagnostics?
- Presentation and S/S?
- Outcome?
- Ashkenazi Jews
- Chromosome 15
- Enzyme assay of serum, WBCs, and cultured fibroblasts
- Clinically normal at birth -> psychomotor regression/retardation @ 6 months
- Progress to blindness, incoordination, flaccidity, mental retardation
- Eventual decerebrate state
- Cherry red macular spot
- Death by 2-3 years
Describe the gross, microscopic, and EM findings seen in Tay-Sachs Disease
Gross: large brain (if survival >2 years)
LM: enlarged, ballooned neurons, astrocytes, and microglia filled with PAS+ material (stored gangliosides)
EM: membranous cytoplasmic bodies
What are some treatment options for Tay-Sachs disease?
Mostly experimental:
- “Chaperone” proteins - help alpha subunit fold normally
- Enzyme replacement therapy
Krabbe’s Disease (Globoid Cell Leukodystrophy)
- Which part of the nervous system is affected?
- Which chromosome is affected?
- Which enzyme is deficient? How does this cause disease?
- Diagnostic approach?
- CNS and PNS
- Chromosome 14
- galactocerebroside-B-galactosidase
- Causes accumulation of psychosine that injures oligodendrocytes
- Galactocerebroside (myelin component) accumulates in “Globoid” cells
- Dx: enzyme assay of WBCs or cultured fibroblasts
Describe the clinical course of Krabbe’s Disease (Globoid Cell Leukodystrophy)
Describe the treatment option(s)
- Normal early development with onset of symptoms around 3-6 months
- irritability, halted development
- deterioration of motor function, including tonic spasms, opisthotonic posture, and myotonic jerking
- Optic atrophy, blindness
- Elevated CSF protein
- Death by approximately 2 years
Rx: umbilical cord blood or bone marrow transplantation. Must begin in pre-symptomatic phase
Describe Krabbe’s Disease:
- Grossly
- LM
- EM
- Gross: atrophic brain with firm, atrophic white matter and preservation of “U” fibers
- LM
- Loss of myelin
- Globoid (giant/macrophage) accumulated around vessels
- Background of reactive astrocytosis
- Decreased oligodendrocytes
- EM: globoid cells contain crystalloid with straigt/tubular profiles
Metachromatic Leukodystrophy
- Affected chromosome?
- Deficient enzyme?
- Accumulated substance? Which organ system(s)?
- Dx?
- Chromosome 22
- Aryl sulfatase A
- Metachromatic lipids (sulfatides) -> brain, peripheral nerves, kidney -> leads to breakdown of myelin
- Dx: screen urine for metachromatic deposits, demonstrate enzyme deficiency in urine, WBCs, or fibroblasts
Contrast the clinical presentation of metachromatic leukodystrophy in a child to that in an adult.
What is the treatment in either case?
Child: presents with gait disorder and motor symptoms
Adult: usually presents first with psychosis and cognitive impairment with later progression to motor symptoms
Rx: bone marrow stem cell transplantation (before symptoms appear)
describe the gross appearance/consistency of the white matter in metachromatic leukodystrophy
Normal brain surface with marked loss of myelin with preservation of “U” fibers
The white matter is very firm
LM: metachromasia of white matter deposits (brown staining with acidified cresyl violet stain)